These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29233098)

  • 1. Intractable ascites associated with mycophenolate in a simultaneous kidney-pancreas transplant patient: a case report.
    Weber NT; Sigaroudi A; Ritter A; Boss A; Lehmann K; Goodman D; Farese S; Weiler S; Mueller TF
    BMC Nephrol; 2017 Dec; 18(1):360. PubMed ID: 29233098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal infection at onset of mycophenolic acid-associated chronic diarrhea in kidney transplant recipients.
    von Moos S; Cippà PE; Wüthrich RP; Mueller TF
    Transpl Infect Dis; 2016 Oct; 18(5):721-729. PubMed ID: 27502733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the exposure of mycophenolate mofetil and enteric-coated mycophenolate sodium in recipients of kidney-pancreas transplantation.
    Belliere J; Esposito L; Gandia P; Duffas JP; Sallusto F; Cardeau-Desangles I; Del Bello A; Rostaing L; Kamar N
    Ann Transplant; 2014 Feb; 19():76-81. PubMed ID: 24509827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?
    Biller P; Michaux L; Pauw LD; Camboni A; Mourad M; Kanaan N
    Acta Clin Belg; 2015 Jun; 70(3):218-22. PubMed ID: 25541210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic features and outcome of mycophenolate-induced colitis in renal transplant recipients.
    de Andrade LG; Rodrigues MA; Romeiro FG; Garcia PD; Contti MM; de Carvalho MF
    Clin Transplant; 2014 Nov; 28(11):1244-8. PubMed ID: 25142167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory ascites induced by mycophenolate in a pediatric kidney transplant patient.
    Kim JY; Jang JH; Cho H
    Clin Nephrol; 2021 Apr; 95(4):215-220. PubMed ID: 33560222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
    Langone A; Shihab F; Pankewycz O; Doria C; Wiland A; McCague K; Chan L
    Clin Transplant; 2014 Sep; 28(9):961-7. PubMed ID: 24893821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
    Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens.
    Girman P; Lipar K; Koznarova R; Boucek P; Kriz J; Kocik M; Havrdova T; Adamec M; Saudek F
    Transplant Proc; 2010; 42(6):1999-2002. PubMed ID: 20692391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage.
    Kaufman DB; Leventhal JR; Koffron A; Gheorghiade M; Elliott MD; Parker MA; Abecassis MM; Fryer JP; Stuart FP
    Surgery; 2000 Oct; 128(4):726-37. PubMed ID: 11015108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients.
    Graff J; Scheuermann EH; Brandhorst G; Oellerich M; Gossmann J
    Ther Drug Monit; 2016 Jun; 38(3):388-92. PubMed ID: 26829599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
    Staatz CE; Tett SE
    Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium.
    Kamar N; Oufroukhi L; Faure P; Ribes D; Cointault O; Lavayssiere L; Nogier MB; Esposito L; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Oct; 20(10):2231-6. PubMed ID: 16046517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids.
    Cristelli MP; Tedesco-Silva H; Medina-Pestana JO; Franco MF
    Transpl Infect Dis; 2013 Aug; 15(4):369-78. PubMed ID: 23701592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil versus enteric-coated mycophenolate sodium after simultaneous pancreas-kidney transplantation.
    Rangel EB; Melaragno CS; Sá JR; Gonzalez AM; Linhares MM; Salzedas A; Medina-Pestana JO
    Transplant Proc; 2009 Dec; 41(10):4265-9. PubMed ID: 20005381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the small bowel of symptomatic kidney transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium.
    Bunnapradist S; Sampaio MS; Wilkinson AH; Pham PT; Huang E; Kuo HT; Anastasi B; Danovitch GM; Lo SK
    Am J Nephrol; 2014; 40(2):184-90. PubMed ID: 25196230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tolerance and safety of conversion from mycophenolate mofetil to enteric-coated mycophenolic acid in renal transplant recipients.
    Qiao LW; Qu QS; Jiang X
    J Biol Regul Homeost Agents; 2017; 31(1):141-146. PubMed ID: 28337883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to Mycophenolate and Fatherhood.
    Midtvedt K; Bergan S; Reisæter AV; Vikse BE; Åsberg A
    Transplantation; 2017 Jul; 101(7):e214-e217. PubMed ID: 28346297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.